Vehmeijer Jim T, Koyak Zeliha, Vink A Suzanne, Budts Werner, Harris Louise, Silversides Candice K, Oechslin Erwin N, Zwinderman Aeilko H, Mulder Barbara J M, de Groot Joris R
Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Department of Cardiology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Congenit Heart Dis. 2019 Nov;14(6):952-957. doi: 10.1111/chd.12847. Epub 2019 Oct 1.
Adult congenital heart disease (ACHD) patients are at risk of sudden cardiac death (SCD). However, methods for risk stratification are not yet well-defined. The T -T (TpTe) interval, a measure of dispersion of ventricular repolarization, is a risk factor for SCD in non-ACHD patients. We aim to evaluate whether TpTe can be used in risk stratification for SCD in ACHD patients.
From an international multicenter cohort of 25 790 ACHD patients, we identified all SCD cases. Cases were matched to controls by age, gender, congenital defect, and (surgical) intervention.
TpTe was measured on a standard 12-lead ECG. The maximum TpTe of all ECG leads (TpTe-max), mean (TpTe-mean), and TpTe dispersion (maximum minus minimum) were obtained. Odds ratios (OR) for SCD cases vs controls were calculated using conditional logistic regression analysis.
ECGs were available for 147 cases (median age at death 33.5 years (quartiles 26.2, 48.7), 66% male) and 267 controls. The mean TpTe-max was 97 ± 24 ms in cases vs 84 ± 17 ms in controls (P < .001); TpTe-mean was 70 ± 16 vs 63 ± 10 ms (P < .001); and dispersion was 51 ± 22 ms vs 41 ± 16 ms (P = .02), respectively. Assessing each ECG lead separately, TpTe in lead aVR predicted SCD most accurately. TpTe in lead aVR was 71 ± 23 ms in cases vs 61 ± 13 ms in controls (P < .001). After adjusting for impaired ventricular function, heart failure symptoms, and prolonged QRS duration, the OR of SCD of TpTe in lead aVR at an optimal cutoff of 80 ms was 5.8 (95% CI 2.7-12.4, P < .001).
The TpTe interval is associated with SCD in ACHD patients. Particularly, TpTe in lead aVR can be used as an independent risk factor for SCD in ACHD patients and may, therefore, add precision to current risk prediction models.
成人先天性心脏病(ACHD)患者存在心源性猝死(SCD)风险。然而,风险分层方法尚未明确界定。T - T(TpTe)间期是心室复极离散度的一个指标,是非ACHD患者SCD的一个危险因素。我们旨在评估TpTe是否可用于ACHD患者SCD的风险分层。
在一个由25790例ACHD患者组成的国际多中心队列中,我们确定了所有SCD病例。根据年龄、性别、先天性缺陷和(手术)干预情况将病例与对照进行匹配。
在标准12导联心电图上测量TpTe。获取所有心电图导联的最大TpTe(TpTe - max)、平均值(TpTe - mean)和TpTe离散度(最大值减去最小值)。使用条件逻辑回归分析计算SCD病例与对照的比值比(OR)。
147例病例(死亡时中位年龄33.5岁(四分位数间距为26.2,48.7),66%为男性)和267例对照的心电图可用。病例组的平均TpTe - max为97±24毫秒,对照组为84±17毫秒(P <.001);TpTe - mean分别为70±16毫秒和对照组63±10毫秒(P <.001);离散度分别为51±22毫秒和41±16毫秒(P =.02)。单独评估每个心电图导联时,aVR导联的TpTe对SCD的预测最准确。病例组aVR导联的TpTe为71±23毫秒,对照组为61±13毫秒(P <.001)。在调整心室功能受损、心力衰竭症状和QRS时限延长后,aVR导联TpTe在最佳截断值80毫秒时SCD的OR为5.8(95%可信区间2.7 - 12.4,P <.001)。
TpTe间期与ACHD患者的SCD相关。特别是,aVR导联的TpTe可作为ACHD患者SCD的独立危险因素,因此可能会提高当前风险预测模型的准确性。